Johnson Matthey Catalysis and Chiral Tecnologies are pleased to offer a continually expanding, novel family of biocatalysts which enhances the chiral capabilities of our chemo-catalyst technology offering.

This combined portfolio of catalytic technology allows the companies to design one of the most effective synthetic routes for their clients.